POSSIBLE ROLE OF PLATELET-ACTIVATING-FACTOR (PAF) IN DISSEMINATED INTRAVASCULAR COAGULATION (DIC), EVIDENCED BY USE OF A PAF ANTAGONIST, CV-3988

被引:61
|
作者
IMURA, Y [1 ]
TERASHITA, Z [1 ]
NISHIKAWA, K [1 ]
机构
[1] TAKEDA CHEM IND LTD,DIV CENT RES,BIOL LABS,YODOGAWA KU,OSAKA 532,JAPAN
关键词
D O I
10.1016/0024-3205(86)90444-3
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
引用
收藏
页码:111 / 117
页数:7
相关论文
共 50 条
  • [1] BENEFICIAL-EFFECTS OF CV-3988, A PLATELET-ACTIVATING-FACTOR (PAF) ANTAGONIST, ON THE DISSEMINATED INTRAVASCULAR COAGULATION (DIC) IN RATS
    IMURA, Y
    TERASHITA, Z
    NISHIKAWA, K
    JAPANESE JOURNAL OF PHARMACOLOGY, 1986, 40 : P153 - P153
  • [2] CV-3988 - A SPECIFIC ANTAGONIST OF PLATELET ACTIVATING FACTOR (PAF)
    TERASHITA, Z
    TSUSHIMA, S
    YOSHIOKA, Y
    NOMURA, H
    INADA, Y
    NISHIKAWA, K
    LIFE SCIENCES, 1983, 32 (17) : 1975 - 1982
  • [3] CV-3988 - A SPECIFIC ANTAGONIST OF PLATELET ACTIVATING FACTOR (PAF)
    TERASHITA, Z
    TSUSHIMA, S
    YOSHIOKA, Y
    NOMURA, H
    INADA, Y
    NISHIKAWA, K
    FOLIA PHARMACOLOGICA JAPONICA, 1984, 83 (05) : P20 - P20
  • [4] EFFECTS OF CV-3988, AN ANTAGONIST OF PLATELET-ACTIVATING-FACTOR (PAF), ON WASHED RABBIT PLATELETS
    COX, CP
    THROMBOSIS RESEARCH, 1986, 41 (02) : 211 - 222
  • [5] THE EFFECTS OF PLATELET-ACTIVATING-FACTOR (PAF) AND A PAF ANTAGONIST (CV-3988) ON SMOKE-INHALATION INJURY IN AN OVINE MODEL
    IKEUCHI, H
    SAKANO, T
    SANCHEZ, J
    MASON, AD
    PRUITT, BA
    JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 1992, 32 (03): : 344 - 350
  • [6] CHARACTERIZATION OF THE ACTIVITY OF A PLATELET-ACTIVATING-FACTOR ANTAGONIST, CV-3988
    HAYASHI, M
    KIMURA, J
    OHISHI, S
    TSUSHIMA, S
    NOMURA, H
    JAPANESE JOURNAL OF PHARMACOLOGY, 1987, 44 (02): : 127 - 134
  • [7] INHIBITION BY CV-3988 OF THE BINDING OF [H-3] PLATELET ACTIVATING FACTOR (PAF) TO THE PLATELET
    TERASHITA, ZI
    IMURA, Y
    NISHIKAWA, K
    BIOCHEMICAL PHARMACOLOGY, 1985, 34 (09) : 1491 - 1495
  • [8] INHIBITORY EFFECT OF TCV-309, A NOVEL PLATELET-ACTIVATING-FACTOR (PAF) ANTAGONIST, ON ENDOTOXIN-INDUCED DISSEMINATED INTRAVASCULAR COAGULATION IN RATS - POSSIBLE ROLE OF PAF IN TISSUE FACTOR GENERATION
    KAWAMURA, M
    TERASHITA, Z
    IMURA, Y
    SHINO, A
    NISHIKAWA, K
    THROMBOSIS RESEARCH, 1993, 70 (04) : 281 - 293
  • [9] PLATELET-ACTIVATING-FACTOR (PAF) ANTAGONISTS - DEVELOPMENT OF THE POTENT PAF ANTAGONIST, CV-6209
    TAKATANI, M
    YOSHIOKA, Y
    TASAKA, A
    TERASHITA, Z
    NISHIKAWA, K
    TSUSHIMA, S
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1987, 76 (11) : S174 - S174
  • [10] EFFECTS OF PLATELET-ACTIVATING-FACTOR ANTAGONIST CV-3988 IN PRESERVATION OF HEART AND LUNG FOR TRANSPLANTATION
    QAYUMI, AK
    JAMIESON, WRE
    POOSTIZADEH, A
    ANNALS OF THORACIC SURGERY, 1991, 52 (04): : 1026 - 1032